<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>HEALTH COSMETICS &#8211; INSIGHT BIOSOLUTIONS</title>
	<atom:link href="https://www.insight-biosolutions.fr/en/category/health-cosmetics/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.insight-biosolutions.fr</link>
	<description>A site using WordPress</description>
	<lastBuildDate>Mon, 15 Nov 2021 15:04:22 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.insight-biosolutions.fr/wp-content/uploads/2021/06/cropped-logo-IBS-32x32.jpg</url>
	<title>HEALTH COSMETICS &#8211; INSIGHT BIOSOLUTIONS</title>
	<link>https://www.insight-biosolutions.fr</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>OECD Guideline 497</title>
		<link>https://www.insight-biosolutions.fr/en/oecd-guideline-497/</link>
		
		<dc:creator><![CDATA[ALINA]]></dc:creator>
		<pubDate>Mon, 11 Oct 2021 18:12:45 +0000</pubDate>
				<category><![CDATA[HEALTH COSMETICS]]></category>
		<guid isPermaLink="false">https://insight-biosolutions.com/?p=1959</guid>

					<description><![CDATA[<p>L’article <a rel="nofollow" href="https://www.insight-biosolutions.fr/en/oecd-guideline-497/">OECD Guideline 497</a> est apparu en premier sur <a rel="nofollow" href="https://www.insight-biosolutions.fr">INSIGHT BIOSOLUTIONS</a>.</p>
]]></description>
										<content:encoded><![CDATA[


<div class="et_pb_section et_pb_section_0 et_section_regular" >
				
				
				
				
				
				
				<div class="et_pb_row et_pb_row_0">
				<div class="et_pb_column et_pb_column_4_4 et_pb_column_0  et_pb_css_mix_blend_mode_passthrough et-last-child">
				
				
				
				
				<div class="et_pb_module et_pb_text et_pb_text_0  et_pb_text_align_center et_pb_bg_layout_light">
				
				
				
				
				<div class="et_pb_text_inner"><p>&#8211; INSIGHT BIOSOLUTIONS &#8211;</p>
<h1><b>New regulatory guidances for using improved and defined approaches in cosmetic safety assessment<br /></b></h1></div>
			</div>
			</div>
				
				
				
				
			</div>
				
				
			</div><div id="insilico" class="et_pb_section et_pb_section_1 et_section_regular" >
				
				
				
				
				
				
				<div class="et_pb_row et_pb_row_1 et_animated">
				<div class="et_pb_column et_pb_column_4_4 et_pb_column_1  et_pb_css_mix_blend_mode_passthrough et-last-child">
				
				
				
				
				<div class="et_pb_module et_pb_text et_pb_text_1  et_pb_text_align_center et_pb_bg_layout_light">
				
				
				
				
				<div class="et_pb_text_inner"><h1><b>11th revision of the SCCS&#8217; Notes of Guidance and OECD guideline 497</b></h1></div>
			</div><div class="et_pb_module et_pb_text et_pb_text_2  et_pb_text_align_center et_pb_bg_layout_light">
				
				
				
				
				<div class="et_pb_text_inner"><p>11th revision of the SCCS&#8217; Notes of Guidance (NoG) for the testing of cosmetic ingredients and their safety evaluation</p>
<p>In comparison with the previous version, this 11th revision of the<a href="https://ec.europa.eu/health/sites/default/files/scientific_committees/consumer_safety/docs/sccs_o_250.pdf" target="_blank" rel="noopener"> SCCS’ notes of Guidance</a>, published on April 2021 , focus on the application of alternative methods, specifically on non-animal methods/new approach methodology (NAM).</p>
<p>This NoG has been revised with a particular emphasis on six main and important changes which including general updating of NAMs and also in silico methodology for genotoxcity/carcinogenicity. The two key benefits of this NoG is to improve harmonized compliance with the current cosmetic EU legislation and to accept finally the alternative methods to animal testing. </p></div>
			</div>
			</div>
				
				
				
				
			</div><div class="et_pb_row et_pb_row_2 et_animated">
				<div class="et_pb_column et_pb_column_4_4 et_pb_column_2  et_pb_css_mix_blend_mode_passthrough et-last-child">
				
				
				
				
				<div class="et_pb_module et_pb_text et_pb_text_3  et_pb_text_align_center et_pb_bg_layout_light">
				
				
				
				
				<div class="et_pb_text_inner"><h3><b>OECD guideline 497: Defined approaches for skin sensitization with in silico, in chemico, in vitro data sources</b></h3></div>
			</div><div class="et_pb_module et_pb_text et_pb_text_4  et_pb_text_align_center et_pb_bg_layout_light">
				
				
				
				
				<div class="et_pb_text_inner"><p>OECD published on the June 14th 2021 a new guideline on <a href="https://www.oecd.org/env/ehs/testing/GL%20DASS_22Sep2019v2.pdf" target="_blank" rel="noopener">Defined Approaches for Skin Sensitization</a>. This new OECD guideline which uses combined different information sources to generate product safety data and thus replace the use of animal test data.</p>
<p>In the defined approaches, the different selected data sources are combined and the resulting data generated is interpretated by a <strong>fixed Data Interpretation Procedure (DIP)</strong>.</p>
<p>Two main benefits of these new defined approaches:</p>
<p>1. these approaches are able to provide equivalent or even more informative information than that generated by the <strong>LLNA method</strong> (<strong>OECD TG429</strong>) for the skin sensitization hazard identification,</p>
<p>2. these approaches are able to overcome the limits of the individual methods.</p>
<p>Insight Biosolutions provides a combined<em> in vitro</em> and <em>in silico</em> services: in vitro regulatory tests and in silico prediction applications with software tools including in these guidelines.<br />The services provided by Insight Biosolutions are in line with the 11th revision of the SCCS’NoG and the new <strong>OECD TG497</strong> guideline.</p></div>
			</div>
			</div>
				
				
				
				
			</div>
				
				
			</div><div class="et_pb_section et_pb_section_2 et_pb_with_background et_section_regular" >
				
				
				
				
				
				
				
				
				
			</div>


<p>L’article <a rel="nofollow" href="https://www.insight-biosolutions.fr/en/oecd-guideline-497/">OECD Guideline 497</a> est apparu en premier sur <a rel="nofollow" href="https://www.insight-biosolutions.fr">INSIGHT BIOSOLUTIONS</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
